Sixteen Korean patients with Leigh syndrome were identified at the Seoul National University Children's Hospital in [2001][2002][2003][2004][2005][2006]. Biochemical or molecular defects were identified in 14 patients (87.5%). Thirteen patients had respiratory chain enzyme defects; 9 had complex I deficiency, and 4 had combined defects of complex I + III + IV. Based on the biochemical defects, targeted genetic studies in 4 patients with complex I deficiency revealed two heteroplasmic mitochondrial DNA mutations in ND genes. One patient had the mitochondrial DNA T8993G point mutation. No mitochondrial DNA defects were identified in 11 (68.7%) of our LS patients, who probably have mutations in nuclear DNA. Although a limited study based in a single tertiary medical center, our findings suggest that isolated complex I deficiency may be the most common cause of Leigh syndrome in Korea.
Introduction
Originally described by Dr. Dennis Leigh in 1951, Leigh syndrome (LS) is a progressive neurodegenerative disorder typically beginning in infancy or childhood and is characterized by symmetrical necrosis in the brain stem, basal ganglia, and thalamus [1] . LS is one of the most common mitochondrial disorders and is caused by heterogeneous genetic and biochemical defects, including deficiencies of pyruvate dehydrogenase complex and mitochondrial respiratory chain enzymes. Because respiratory chain enzyme complexes are encoded in mitochondrial DNA (mtDNA) and nuclear DNA (nDNA), LS can be caused by mutations in either genome [2] [3] [4] . Little is known about LS in the Korean population. In this study, we characterized the clinical, biochemical, and molecular genetic features of 16 Korean patients with LS evaluated at a major tertiary-care pediatric hospital in Seoul. This is the first report describing the molecular genetic and biochemical features of LS in Korea.
Patients and methods
In 2001-2006, 46 patients were evaluated for possible mitochondrial disorders at Seoul National University Childrens' Hospital. All of the patients were screened for other metabolic disorders by analyses of amino acids and organic acids. Sixteen patients were diagnosed with LS based on the following clinical criteria: encephalopathy, psychomotor regression, and characteristic brain magnetic resonance imaging (MRI) with symmetric lesions indicating bilateral necrosis of the basal ganglia, thalamus, and brain stem. None of the patients had MRI findings of central necrosis in the caudate head with involvement of the putamen that are typical of
